Total Payments
$106,699
2024 Payments
$11,009
Companies
10
Transactions
59
Payment Breakdown by Category
Consulting$99,167 (92.9%)
Travel$6,675 (6.3%)
Food & Beverage$857.78 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $99,167 | 17 | 92.9% |
| Travel and Lodging | $6,675 | 25 | 6.3% |
| Food and Beverage | $857.78 | 17 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $31,560 | 22 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $11,009 | 1 | $0 (2024) |
| SANOFI US SERVICES INC. | $10,504 | 7 | $0 (2018) |
| Eli Lilly and Company | $10,500 | 1 | $0 (2021) |
| BioMarin Pharmaceutical Inc. | $9,315 | 1 | $0 (2017) |
| Ipsen Bioscience Inc | $8,550 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,447 | 8 | $0 (2019) |
| HRA Pharma | $7,000 | 1 | $0 (2023) |
| Amarin Pharma Inc. | $6,352 | 16 | $0 (2019) |
| Roche Diabetes Care GmbH | $3,464 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,009 | 1 | AstraZeneca Pharmaceuticals LP ($11,009) |
| 2023 | $13,938 | 2 | HRA Pharma ($7,000) |
| 2022 | $8,550 | 1 | Ipsen Bioscience Inc ($8,550) |
| 2021 | $10,500 | 1 | Eli Lilly and Company ($10,500) |
| 2020 | $6,484 | 5 | Novo Nordisk Inc ($6,484) |
| 2019 | $25,680 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,447) |
| 2018 | $10,504 | 7 | SANOFI US SERVICES INC. ($10,504) |
| 2017 | $20,036 | 9 | Novo Nordisk Inc ($10,721) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $11,008.50 | General |
| 06/26/2023 | HRA Pharma | — | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| 03/21/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $6,937.50 | General |
| 09/16/2022 | Ipsen Bioscience Inc | — | Consulting Fee | Cash or cash equivalent | $8,550.00 | General |
| 11/30/2021 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| 03/13/2020 | Novo Nordisk Inc | Norditropin (Biological) | Consulting Fee | Cash or cash equivalent | $3,825.00 | General |
| Category: Growth Hormone | ||||||
| 03/13/2020 | Novo Nordisk Inc | Norditropin (Biological) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Growth Hormone | ||||||
| 01/30/2020 | Novo Nordisk Inc | Norditropin (Biological) | Travel and Lodging | In-kind items and services | $464.80 | General |
| Category: Growth Hormone | ||||||
| 01/30/2020 | Novo Nordisk Inc | Norditropin (Biological) | Travel and Lodging | In-kind items and services | $323.32 | General |
| Category: Growth Hormone | ||||||
| 01/30/2020 | Novo Nordisk Inc | Norditropin (Biological) | Travel and Lodging | In-kind items and services | $170.79 | General |
| Category: Growth Hormone | ||||||
| 11/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $7,810.00 | General |
| Category: DIABETES | ||||||
| 11/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $239.08 | General |
| Category: DIABETES | ||||||
| 11/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: DIABETES | ||||||
| 11/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Travel and Lodging | Cash or cash equivalent | $38.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | Cash or cash equivalent | $37.18 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $77.58 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $77.58 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $44.46 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $39.79 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Travel and Lodging | In-kind items and services | $112.01 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Hypertriglyceridemia | ||||||
About Dr. Robert Smith, MD
Dr. Robert Smith, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477594901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Smith, MD has received a total of $106,699 in payments from pharmaceutical and medical device companies, with $11,009 received in 2024. These payments were reported across 59 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($99,167).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Providence, RI
- Active Since 06/08/2006
- Last Updated 11/15/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1477594901
Products in Payments
- SOTAGLIFLOZIN (Drug) $10,504
- BMN 190 (Biological) $9,315
- JARDIANCE (Drug) $8,447
- Norditropin (Biological) $6,484
- Vascepa (Drug) $6,352
- Victoza (Drug) $5,997
- Ozempic (Drug) $4,724
- DC ACCU-CHEK Diabetes Management Solutions, Cables, Software, Kits and Accessories (Device) $3,464
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Providence
Robert Dobrzynski, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $355,413
Endocrinology, Diabetes & Metabolism $355,413
Dr. Joseph Tucci, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $50,880
Endocrinology, Diabetes & Metabolism $50,880
Kenneth Chen, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,625
Endocrinology, Diabetes & Metabolism $11,625
Roberto Ortiz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $493.63
Endocrinology, Diabetes & Metabolism $493.63
Charles Kahn, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $249.96
Endocrinology, Diabetes & Metabolism $249.96
Ivana Lukacova-Zib, M.d, M.D
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism